Tag: Alzheimer’s
Antipsychotic Initiation Ups Risk for Head Injury, TBI in Alzheimer Disease
TBI injury risk up for quetiapine versus risperidone users
Tau-PET Signal Predicts Atrophy in Early Alzheimer Disease
Association between baseline tau-PET and subsequent atrophy particularly strong in younger patients
2007 to 2014 Saw Decrease in U.S. Incidence of Alzheimer Disease
Incidence varied considerably by region, ranging from 0 to more than 3 percent across population areas in 2014
More Hospital Days Seen With Antipsychotic Use in Alzheimer Disease
Number of hospital days up by more than 50 percent in AD patients initiating antipsychotic medication
Dementia Common in Down Syndrome Patients Aged ≥55
Dementia incidence 102 cases per 1,000 person-years for individuals aged 55 years or older
Early-Stage Alzheimer Disease Has Adverse Financial Consequences
Robust evidence shows households are at significant risk for large adverse changes in liquid assets
New Alzheimer Disease Drug to Be Submitted for FDA Approval
New analysis of study results suggests highest dose of aducanumab may help slow cognitive decline
Long Sleep Duration Linked to Cognitive Decline in Hispanics
Long sleep duration predicts seven-year cognitive decline in U.S. Hispanics/Latinos
Sex-Specific Criteria May Up Accuracy for Diagnosis of aMCI
Non-sex-specific criteria less accurate for diagnosis of amnestic mild cognitive impairment
Exercise May Slow Brain Deterioration in Alzheimer Disease
Findings did not differ between aerobic exercise and stretching and toning
